Literature DB >> 8114610

Effect of cocaine and murine AIDS on lamina propria T and B cells in normal mice.

M C Lopez1, R R Watson.   

Abstract

We developed an experimental model to study the effect of daily cocaine administration on the mucosal immune system during murine acquired immune deficiency syndrome (MAIDS). Mice were infected with LP-BM5 murine leukemia virus, a retrovirus which causes immunosuppression with development of functional murine AIDS. Mice were given cocaine by daily intraperitoneal injection for 11 weeks. Our objective was to investigate if cocaine treatment could alter the mucosal immune system at the level of the intestinal lamina propria (ILP) and if it could further modify the already altered mucosal immunity when it was administered to MAIDS-mice. Daily cocaine administration induced a significant decrease in the number of IgA+ cells with a concomitant increase in the number of CD8+ cells per villi in the ILP. Murine retrovirus infection alone decreased the number of IgA+ and CD4+ cells in the ILP, and this decreased was even more marked when MAIDS mice also received cocaine. These data indicate that cocaine administration could potentiate the dramatic effect that MAIDS infection has in the mucosal-associated lymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114610     DOI: 10.1016/0024-3205(94)00874-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

Review 1.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

2.  The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.

Authors:  Howard Minkoff; Ye Zhong; Howard D Strickler; D Heather Watts; Joel M Palefsky; Alexandra M Levine; Gypsyamber D'Souza; Andrea A Howard; Michael Plankey; L Stewart Massad; Robert Burk
Journal:  Infect Dis Obstet Gynecol       Date:  2008
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.